Squeezing more production out of bacteria
MIT chemical engineers demonstrate a new way to dramatically boost bacteria’s manufacturing abilities.
From sponges, a potential cancer drug
MIT chemists have synthesized a family of natural compounds that have shown promise in killing tumor cells.
Why saliva forms beads on a string
Researchers’ solution to longstanding mystery could enable better inkjet printing and drug-dispensing systems.
MIT’s Koch Institute in strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals
Organizations will collaborate in multiple areas of oncology research and technology development.
An easier way to synthesize new drug candidates
MIT chemists’ answer to long-standing problem could have a big impact on pharmaceutical business.
Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.
Biomanufacturing Research Program wins grant from Sloan Foundation
Will be used to examine globalization and regulatory compliance
